Recent advances in the immunologic portrait of TNBC show the tumor is characterized by a unique microenvironment with higher levels of lymphocyte infiltration and PD-L1 expression than other BC subtypes and also has a more significant number of somatic mutations due to genomic instability, leading to the frequent presence of neoantigens [87]. This evidence concerns the gene CD274 and breast cancer.